Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Aurora Cannabis Inc. (ACB) vs Anika Therapeutics Inc. (ANIK)

Aurora Cannabis Inc. and Anika Therapeutics Inc. are both Drug Manufacturers Specialty & Generic companies. Aurora Cannabis Inc. and Anika Therapeutics Inc. are of similar size ($270.7M and $267.8M). Anika Therapeutics Inc. grew revenue faster over the last twelve months: 5.33% against −18.2%. Anika Therapeutics Inc. has the higher net margin (−3.14% vs −38.1%) and the higher return on invested capital (−3.24% vs −5.58%). Across the 18 metrics below, Anika Therapeutics Inc. leads on 12 and Aurora Cannabis Inc. on 6.

Valuation

Metric ACB ANIK Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 1.20 2.25 2.25
P/B 0.66 1.98 1.90
Price to free cash flow n/m 483.15 16.54
EV/EBITDA n/m 508.54 12.29
EV/Sales 0.96 2.16 2.56
Earnings yield (34.39%) (1.28%) (2.99%)
Free cash flow yield (14.28%) 0.21% 0.00%

Profitability

Metric ACB ANIK Drug Manufacturers Specialty & Generic median
Gross margin 49.74% 62.16% 53.94%
Operating margin (12.13%) (4.24%) 0.00%
Net margin (38.12%) (3.14%) 0.00%
Free cash flow margin (17.19%) 0.47% 0.00%
Return on equity (19.85%) (2.66%) (0.40%)
Return on assets (15.19%) (2.04%) (3.32%)
Return on invested capital (5.58%) (3.24%) 0.00%

Growth

Metric ACB ANIK Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (18.18%) 5.33% 10.01%
EPS growth (last fiscal year) (5,266.67%) 80.16% —
Revenue growth, 5-year CAGR 3.92% (2.86%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACB ANIK Drug Manufacturers Specialty & Generic median
Debt to equity 0.03 0.00 0.05
Current ratio 5.36 4.48 2.31
Net debt to EBITDA 5.11 10.80 0.85

Dividend

Metric ACB ANIK Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric ACB ANIK Drug Manufacturers Specialty & Generic median
Market cap 267.79m 270.74m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack